Last $0.20 USD
Change Today 0.00 / 0.00%
Volume 0.0
FNAM On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 12/11/14 All times are local (Market data is delayed by at least 15 minutes).

fona inc (FNAM) Snapshot

Open
$0.20
Previous Close
$0.20
Day High
$0.20
Day Low
$0.20
52 Week High
03/17/14 - $0.90
52 Week Low
02/6/14 - $0.19
Market Cap
1.6M
Average Volume 10 Days
300.6
EPS TTM
--
Shares Outstanding
7.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for FONA INC (FNAM)

Related News

No related news articles were found.

fona inc (FNAM) Related Businessweek News

No Related Businessweek News Found

fona inc (FNAM) Details

Fona, Inc. does not have significant operations. The company intends to locate and consummate a merger or acquisition with a private entity. Previously, it was engaged in the provision of Internet-based Rent411 services. The company was formerly known as Fonahome Corporation and changed its name to Fona, Inc. in March 2009. Fona, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado. Fona, Inc. is a subsidiary of Evolutionary Genomics, Inc.

fona inc (FNAM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

fona inc (FNAM) Key Developments

Fona, Inc. Announces Management Changes

Virginia Orndorff and Mark Boggess were appointed as directors of the Fona, Inc. by the Board, effective 10 days after an information statement on Schedule 14F-1 is mailed to the company's shareholders and (ii) Messrs. Friess and Schwartz's voluntarily resigned as officers and directors of the company, effective immediately. Mr. Friess, the company's President and principal executive officer, resigned from such positions on October 1, 2014. Steve B. Warnecke was appointed Chief Financial Officer, Treasurer, Secretary and member of the board of directors of Fona on June 6, 2014, and became its principal executive officer as President, Chief Executive Officer and Chairman of the Board on October 1, 2014. Mr. Warnecke has served as a member of the board of directors of Evolutionary Genomics since September 2010 and was appointed as Chief Executive Officer in November 2010. Since November 2012, Mr. Warnecke has served part-time roles as Chairman of the Board of Directors and Chief Financial Officer for VetDC, Inc. and Senior Vice President of Children's Hospital Colorado Foundation and Chairman of Children's Partners Foundation (supporting Children's Hospitals and cystic fibrosis research) since November 2011. He also is a member of the Board of Directors of CereScan and Bone Biologics, Inc. Virginia Orndorff was appointed as a director of the company on October 1, 2014. She has served as a member of the Evolutionary Genomics board of directors since 2000. Since 2012 Ms. Orndorff has served as Chief Executive Officer of SixOne Solutions, LLC. She also currently serves on Colorado's State Board of Pharmacy since 2012. Mark Boggess, Ph.D. was appointed as a director of the company on October 1, 2014. He has served as a director of Evolutionary Genomics since 2009. Dr. Boggess has a diverse background in the animal sciences and animal industries. Currently, Dr. Boggess serves as the Director of the U.S. Dairy Forage Research Center in Madison, WI. Walter Messier, Ph.D. was appointed Secretary and Treasurer of the company on October 1, 2014. He is a Founder of Evolutionary Genomics and has served as its Chief Technology Officer since 2000 and has served as its Secretary since 2007.

Fona, Inc. announced delayed 10-Q filing

On 08/14/2014, Fona, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Fona, Inc. Announces Management Changes

On June 6, 2014, Chloe DiVita voluntarily resigned as Chief Financial Officer, Secretary, Treasurer and member of the board of directors of Fona, Inc. Ms. DiVita's resignation was not the result of any disagreement with the company on any matter relating to its operations, policies (including accounting or financial policies) or practices. On June 6, 2014, the board appointed Steve Warnecke to serve as a director, Secretary, Treasurer and Chief Financial Officer of the company, to fill the vacancies created by the resignation of Ms. DiVita. Mr. Warnecke shall hold office until the next annual meeting of stockholders of the company and until his successor is elected and qualified or until his earlier death, incapacity, resignations or removal. Steve Warnecke has served as a member of the board of directors of Evolutionary Genomics since September 2010 and was appointed as Chief Executive Officer in November 2010. Since November 2012, Mr. Warnecke has served part-time roles as Chairman of the board of directors and Chief Financial Officer for VetDC, Inc. and Senior Vice President of Children's Hospital Colorado Foundation and Chairman of Children's Partners Foundation (supporting Children's Hospitals and cystic fibrosis research) since November 2011. Previously, Mr. Warnecke served as Lead Independent Director and Audit Committee Chair for Evolving Systems, Inc. from 2003 to 2011, as Chief Financial Officer of Targeted Medical Pharma, Inc. in 2011, as Chief Financial Officer and member of the Board of Directors for Bacterin International, Inc. from 2008 to 2010, Chief Financial Officer for The Children's Hospital Foundation from 2003 to 2008, member of the Board of Directors of Emmaus Life Sciences, Inc. in 2011, member of the Board of Directors of Boppy Company from 2005 to 2008, Senior Vice-President of Strategic Planning for First Data/Western Union from 2001 to 2002 and Chief Financial Officer for Frontier Airlines from 1999 to 2001.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FNAM:US $0.20 USD 0.00

FNAM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FNAM.
View Industry Companies
 

Industry Analysis

FNAM

Industry Average

Valuation FNAM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FONA INC, please visit www.fonainc.com/. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.